MEDIASTINAL METASTASES IN BRONCHOGENIC-CARCINOMA - INFLUENCE OF POSTOPERATIVE IRRADIATION, CELL TYPE, AND LOCATION
MEDIASTINAL METASTASES IN BRONCHOGENIC-CARCINOMA - INFLUENCE OF POSTOPERATIVE IRRADIATION, CELL TYPE, AND LOCATION
复制标题
DOI:
10.1016/s0003-4975(10)60786-2
复制
发表时间:
1982-01-01
影响因子:
4.6
通讯作者:
SLOAN, H
中科院分区:
文献类型:
--
作者:
KIRSH, MM;SLOAN, H
A 17-yr experience with 136 patients with bronchogenic carcinoma and mediastinal metastases is reported. Six died postoperatively. Postoperative mediastinal irradiation was given to 110 patients surviving curative resection who had evidence of tumor spreading to the mediastinal lymph nodes. The remaining 20 patients did not receive radiation therapy. Of the 136 patients, 29 (21.3%) lived 5 yr free from disease; 9 survived 10 or more yr. Of the 110 patients who survived operation and underwent irradiation, 29 (26.4%) survived 5 yr. None of the 20 patients not receiving radiation therapy lived 5 yr. Of the patients who underwent irradiation, 18 of the 50 patients with squamous cell carcinoma survived 5 yr; only 7 of 55 with adenocarcinoma survived 5 yr. The discovery of mediastinal lymph node involvement in bronchogenic carcinoma probably is not a contraindication to pulmonary resection. As in previous reports, histological cell type has proved to be an important indicator of absolute survival. Patients with squamous cell carcinoma had an absolute 5-yr survival of 33.9%; the patients with adenocarcinoma has an absolute survival of 12.3%. The level of lymph node metastasis has an influence on prognosis as well. Patients with subcarinal lymph node metastases had a lower survival than patients with superior mediastinal involvement.